← Eichor
Study identifier: NCT06615453 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease

Condition: Dry Eye Disease (DED)  ·  Sponsor: Aston University

PhaseNA
Planned participants36
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will examine how a standard Tixel treatment versus a sham treatment for eye wrinkles affects the symptoms and signs of Dry Eye Disease.

This description comes directly from the study's public registry record.

Talk to the study team

Sunil Shah, MD  ·  +44 121 711 2020  ·  s.shah26@aston.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Vision Science, School of OptometryBirmingham, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06615453